Author:
Gericke Janine,Metz Martin,Ohanyan Tatevik,Weller Karsten,Altrichter Sabine,Skov Per Stahl,Falkencrone Sidsel,Brand Janko,Kromminga Arno,Hawro Tomasz,Church Martin K.,Maurer Marcus
Subject
Immunology,Immunology and Allergy
Reference12 articles.
1. Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials;Zhao;J Allergy Clin Immunol,2016
2. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update;Zuberbier;Allergy,2014
3. On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach;Meno-Tetang;Basic Clin Pharmacol Toxicol,2005
4. A serological mediator in chronic idiopathic urticaria–a clinical, immunological and histological evaluation;Grattan;Br J Dermatol,1986
5. Omalizumab normalises levels of high affinity IgE receptor-positive skin cells in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study;Metz;Allergy,2014
Cited by
188 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献